MDL 11939
SIGMA/SML0115 - ≥98% (HPLC)
Synonym: α-Phenyl-1-(2-phenylethyl)-4-piperidinemethanol; Glemanserin; MDL11939
CAS Number: 107703-78-6
Empirical Formula (Hill Notation): C20H25NO
Molecular Weight: 295.42
MDL Number: MFCD00864701
Linear Formula: C20H25NO
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to tan |
| form | powder |
| InChI | 1S/C21H27NO/c23-21(19-11- |
| InChI key | CTDVLAJTGZQELM-UHFFFAOYSA |
| originator | Sanofi Aventis |
| Quality Level | 100 ![]() |
| SMILES string | OC(C1CCN(CCC2=CC=CC=C2)CC |
| solubility | DMSO: ≥8 mg/mL |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | MDL 11,939 is a potent, selective and orally active 5-HT2 receptor antagonist (ASTAR). Ki values values are in the low nanomolar range for 5-HT2A with over 100-fold selectivity over 5-HT2C receptors and low or no affinity for non-5-HT2 receptors or transporters. |
| Biochem/physiol Actions: | Potent, selective, and orally active 5-HT2 receptor antagonist (ASTAR) |
| Features and Benefits: | This compound was developed by Sanofi Aventis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS09 |
| Signal word | Warning |
| Hazard statements | H400 |
| Precautionary statements | P273 |
| Hazard Codes | N |
| Risk Statements | 50/53 |
| Safety Statements | 60-61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


